Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients

por Chantzichristos, Dimitrios, Andréasson, Björn, Johansson, Peter
Publicado 2008

The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis

por Pettersson, Helna, Adamsson, Jenni, Johansson, Peter, Nilsson, Staffan, Palmqvist, Lars, Andréasson, Björn, Asp, Julia
Publicado 2023

Distinct Inflammatory Mediator Patterns Characterize Infectious and Sterile Systemic Inflammation in Febrile Neutropenic Hematology Patients

por Wennerås, Christine, Hagberg, Lars, Andersson, Rune, Hynsjö, Lars, Lindahl, Anders, Okroj, Marcin, Blom, Anna M., Johansson, Peter, Andreasson, Björn, Gottfries, Johan, Wold, Agnes E.
Publicado 2014

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

por Hjorth, Martin, Hjertner, Øyvind, Knudsen, Lene Meldgaard, Gulbrandsen, Nina, Holmberg, Erik, Pedersen, Per Trøllund, Andersen, Niels Frost, Andréasson, Björn, Billström, Rolf, Carlson, Kristina, Carlsson, Margaretha S, Flogegård, Max, Forsberg, Karin, Gimsing, Peter, Karlsson, Torbjörn, Linder, Olle, Nahi, Hareth, Othzén, Annika, Swedin, Agneta
Publicado 2012

Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study

por Guglielmelli, Paola, Ghirardi, Arianna, Carobbio, Alessandra, Masciulli, Arianna, Maccari, Chiara, Mora, Barbara, Rumi, Elisa, Triguero, Ana, Finazzi, Maria Chiara, Pettersson, Helna, Paoli, Chiara, Mannelli, Francesco, Vanni, Daniele, Rambaldi, Alessandro, Passamonti, Francesco, Alvarez-Larràn, Alberto, Andreasson, Bjorn, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado 2022

Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score

por Barbui, Tiziano, Ghirardi, Arianna, Carobbio, Alessandra, Masciulli, Arianna, Carioli, Greta, Rambaldi, Alessandro, Finazzi, Maria Chiara, Bellini, Marta, Rumi, Elisa, Vanni, Daniele, Borsani, Oscar, Passamonti, Francesco, Mora, Barbara, Brociner, Marco, Guglielmelli, Paola, Paoli, Chiara, Alvarez-Larran, Alberto, Triguero, Ana, Garrote, Marta, Pettersson, Helna, Andréasson, Björn, Barosi, Giovanni, Vannucchi, Alessandro Maria
Publicado 2022

Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial

por Schmitz, Alexander, Brøndum, Rasmus Froberg, Johnsen, Hans Erik, Mellqvist, Ulf-Henrik, Waage, Anders, Gimsing, Peter, op Bruinink, Davine Hofste, van der Velden, Vincent, van der Holt, Bronno, Hansson, Markus, Andersen, Niels Frost, Frølund, Ulf Christian, Helleberg, Carsten, Schjesvold, Fredrik H., Ahlberg, Lucia, Gulbrandsen, Nina, Andreasson, Bjorn, Lauri, Birgitta, Haukas, Einar, Bødker, Julie Støve, Roug, Anne Stidsholt, Bøgsted, Martin, Severinsen, Marianne T., Gregersen, Henrik, Abildgaard, Niels, Sonneveld, Pieter, Dybkær, Karen
Publicado 2022